EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Noninvasive fetal antigen genotyping: Results from a survey on the status of clinical implementation

Frederik Banch Clausen iD, Åsa Hellberg, Cécile Toly-Ndour iD, Emilie Thorup Nielsen, Masja de Haas iD, Noninvasive Fetal Antigen Genotyping Survey Group

Vox Sanguinis · 2025

DOI: 10.1111/vox.70062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vox Sanguinis, 2025. Verfasst von Frederik Banch Clausen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Blood Genetics, Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Rh-Hr Blood-Group System, Genotyping Techniques, Prenatal Diagnosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS, The Danish Blood Donors' Research Foundation, Clinical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Noninvasive fetal antigen genotyping can assist the management of immunized pregnant women, and fetal RHD genotyping can be used as a screening assay to guide restricted use of Rh prophylaxis. Based on a survey, we present an overview of the implementation of noninvasive fetal antigen genotyping into clinical practice. Materials and Methods A survey was developed and sent out to the members of the International Society of Blood Transfusion (ISBT) working party on Red Cell Immunogenetics and Blood Group Terminology and to participants of the international noninvasive fetal RHD genotyping programme from the Danish Institute for External Quality Assurance for Laboratories in the health sector (DEKS). The survey contained four sections: fetal RHD screening, fetal RHD genotyping for RhD immunized women, fetal genotyping of other antigen targets than RhD and a section for collecting topics for future collaboration. The survey data were evaluated by the core author group.

Results

Fifty‐two survey responders were from 22 countries. Fetal RHD screening was implemented by 73%, foremost using real‐time PCR with in‐house assays, primarily, or commercially available kits. Most laboratories use the same assay for RhD immunized women. Thirty‐eight percent of the responders test for other antigen targets than RhD, using either real‐time PCR, droplet digital PCR (ddPCR) or DNA sequencing. There was an interest in collaborations on topics across methodology, technology, strategy and health care regulations.

Conclusion

In general, we found that noninvasive fetal blood group antigen genotyping is well implemented. However, our results are biased towards high‐income countries, Europe and laboratories already running noninvasive fetal antigen genotyping.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rh-Hr Blood-Group SystemGenotyping TechniquesPrenatal DiagnosisHumansFemalePregnancySurveys and QuestionnairesGenotype

Stichwörter der Autor:innen

HDFNRhDblood groupcell‐free fetal DNAprophylaxis

Substanzen

Rh-Hr Blood-Group SystemRho(D) antigen

Autor:innen und Institutionen

  • Laboratory of Blood Genetics, Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • cfDNA Subgroup from the International Society of Blood Transfusion (ISBT) Working Party on Red Cell Immunogenetics and Blood Group Terminology (RCIBGT), Amsterdam, The Netherlands.
  • Department of Clinical Immunology and Transfusion Medicine, Office of Medical Service, Region Skåne, Lund, Sweden.
  • Laboratory of the French National Reference Center in Perinatal Hemobiology, Assistance Publique des de Paris (AP-HP), Paris, France.
  • Center of Fetal Medicine, Department of Gynecology, Fertility and Pregnancy, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Department of Immunohaematology Diagnostic Services, Sanquin Diagnostic Services and Sanquin Research, Amsterdam, The Netherlands.

ORCID-Profile: Frederik Banch Clausen, Cécile Toly-Ndour, Masja de Haas

Förderung

  • Intramural NIH HHS
  • The Danish Blood Donors' Research Foundation
  • Clinical Center

Zitieren

APA

Clausen, F. B., Hellberg, Å., Toly-Ndour, C., Nielsen, E. T., de Haas, M., & Noninvasive Fetal Antigen Genotyping Survey Group (2025). Noninvasive fetal antigen genotyping: Results from a survey on the status of clinical implementation. Vox Sanguinis. https://doi.org/10.1111/vox.70062

Vancouver

Clausen FB, Hellberg Å, Toly-Ndour C, Nielsen ET, de Haas M, Noninvasive Fetal Antigen Genotyping Survey Group. Noninvasive fetal antigen genotyping: Results from a survey on the status of clinical implementation. Vox Sanguinis. 2025. doi:10.1111/vox.70062

BibTeX
@article{Clausen2025,
  author = {Clausen, Frederik Banch and Hellberg, Åsa and Toly-Ndour, Cécile and Nielsen, Emilie Thorup and de Haas, Masja and Noninvasive Fetal Antigen Genotyping Survey Group, Noninvasive Fetal Antigen Genotyping Survey Group},
  title = {Noninvasive fetal antigen genotyping: Results from a survey on the status of clinical implementation},
  journal = {Vox Sanguinis},
  year = {2025},
  doi = {10.1111/vox.70062}
}
Kostenlos starten →